MARKET

IDXG

IDXG

Interpace Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.500
-0.390
-7.98%
Closed 16:00 04/03 EDT
OPEN
4.740
PREV CLOSE
4.890
HIGH
4.750
LOW
4.300
VOLUME
69.20K
TURNOVER
--
52 WEEK HIGH
11.00
52 WEEK LOW
3.810
MARKET CAP
17.19M
P/E (TTM)
-0.0748
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average IDXG stock price target is 20.80 with a high estimate of 31.00 and a low estimate of 15.00.

EPS

IDXG News

More
  • Interpace Biosciences CEO Jack Stover On Diagnostics Business: 'Much Of The Growth Opportunity Is Around Awareness'
  • Benzinga · 4d ago
  • Interpace Diagnostics Issues Update Regarding Announced Contract with BCBS of Massachusetts
  • Benzinga · 03/12 09:18
  • Interpace Diagnostics Issues Update Regarding Announced Contract with BCBS of Massachusetts
  • GlobeNewswire · 03/12 02:25
  • Interpace nabs new contract for thyroid tests
  • seekingalpha · 03/10 16:36

Industry

Managed Health care
-3.88%
Healthcare Providers & Services
-3.12%

Hot Stocks

Symbol
Price
%Change

About IDXG

Interpace Biosciences, Inc., formerly Interpace Diagnostics Group, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, it provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
More

Webull offers kinds of Interpace Biosciences Inc stock information, including NASDAQ:IDXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXG stock news, and many more online research tools to help you make informed decisions.